- Home
- / Webinars & Videos
- / Making 7-color Multiplex Fluorescent IHC a Breeze; the New Fully Optimized Opal™ MOTiF™ PD1/PD-L1 Panel Kits for Lung Cancer and Melanoma on the BOND RX
Making 7-color Multiplex Fluorescent IHC a Breeze; the New Fully Optimized Opal™ MOTiF™ PD1/PD-L1 Panel Kits for Lung Cancer and Melanoma on the BOND RX
Posted on
Iterative multiplex immunohistochemistry (IHC) can be challenging. In this webinar, we’ll introduce two new fully optimized and ready-to-use Opal MOTiF 7-color I/O panels for full automation staining. We’ll discuss basic tips and tricks for customization as well as the pre-analytical considerations to make every stain a success. You will learn:
- How to use these new ‘plug-and-play’ Opal kits to simplify your high-throughput translational workflow
- How to leverage the MOTif whole slide multispectral scanning and analysis for fast and accurate cellular and tissue phenotyping with these kits
- Get tips and tricks for customizing with your own antibodies

Share This Post
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…